Brooten K E
Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):597-9. doi: 10.1177/106002808602000721.
The legal ramifications of diagnosis-related groups (DRGs) on the health-care system in general and on pharmacists in particular are undetermined. As pharmacists continue to play an increasing role in therapeutic decisions, their exposure to malpractice suits will continue to rise. Pharmacists' liability in medical malpractice actually began prior to the introduction of DRGs, with the adoption by many states of "generic substitute" laws. Situations that can lead to judgments against pharmacists are reviewed. The majority rule of joint and several liability is explained. The conclusion that "DRGs are not a legal defense" is underscored by a dramatic presentation of a hypothetical court case.
诊断相关分组（DRGs）对整个医疗保健系统，尤其是对药剂师的法律影响尚不确定。随着药剂师在治疗决策中继续发挥越来越大的作用，他们面临医疗事故诉讼的风险将持续上升。药剂师在医疗事故中的责任实际上在DRGs引入之前就已开始，当时许多州通过了“通用替代”法律。本文回顾了可能导致对药剂师不利判决的情况。解释了连带责任的多数规则。通过一个假设的法庭案例的生动呈现，强调了“DRGs不是法律抗辩理由”这一结论。
